Showing results (781-790 of 853) with videos related to

Sort By:
Pageof 86
The Lancet Regional Health. Europe|July 1, 2026
Andes Virus on a Cruise Ship, what it Tells us About the Global Pandemic Preparedness AgendaMarion Koopmans, Christian Brechot, Roberto Bruzzone, et al.
Cell Reports|May 20, 2020
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV InfectionsHuibin Lv, Nicholas C Wu, Owen Tak-Yin Tsang, et al.
Nature Medicine|January 20, 2022
Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccinationSamuel M S Cheng, Chris Ka Pun Mok, Yonna W Y Leung, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2021
Surface-aerosol stability and pathogenicity of diverse MERS-CoV strains from 2012 - 2018Neeltje van Doremalen, Michael Letko, Robert J Fischer, et al.
Cell Reports|January 27, 2021
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV InfectionsHuibin Lv, Nicholas C Wu, Owen Tak-Yin Tsang, et al.
Lancet (London, England)|June 4, 2013
Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistanceYunwen Hu, Shuihua Lu, Zhigang Song, et al.
Nature Communications|April 27, 2023
Resurgence of Omicron BA.2 in SARS-CoV-2 infection-naive Hong KongRuopeng Xie, Kimberly M Edwards, Dillon C Adam, et al.
Journal of Virology|September 2, 2011
Tissue tropism of swine influenza viruses and reassortants in ex vivo cultures of the human respiratory tract and conjunctivaRenee W Y Chan, Sara S R Kang, Hui-Ling Yen, et al.
Cell|April 22, 2008
Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injuryYumiko Imai, Keiji Kuba, G Greg Neely, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2022
Immunogenicity of a Third Dose of BNT162b2 to Ancestral Severe Acute Respiratory Syndrome Coronavirus 2 and the Omicron Variant in Adults Who Received 2 Doses of Inactivated VaccineNancy H L Leung, Samuel M S Cheng, Mario Martín-Sánchez, et al.
Pageof 86